159 related articles for article (PubMed ID: 11672464)
1. Risk factors for toxoplasmic encephalitis in HIV-infected patients: a case-control study in Brazil.
Nascimento LV; Stollar F; Tavares LB; Cavasini CE; Maia IL; Cordeiro JA; Ferreira MU
Ann Trop Med Parasitol; 2001 Sep; 95(6):587-93. PubMed ID: 11672464
[TBL] [Abstract][Full Text] [Related]
2. Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
Ribera E; Fernandez-Sola A; Juste C; Rovira A; Romero FJ; Armadans-Gil L; Ruiz I; Ocaña I; Pahissa A
Clin Infect Dis; 1999 Dec; 29(6):1461-6. PubMed ID: 10585796
[TBL] [Abstract][Full Text] [Related]
3. [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].
Koch A; Kothe H; Braun J; Kämmerer R; Friedrich HJ; Dalhoff K
Pneumologie; 1998 Nov; 52(11):614-21. PubMed ID: 9885511
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
[TBL] [Abstract][Full Text] [Related]
5. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation and outcome of toxoplasmic encephalitis in patients with human immunodeficiency virus type 1 infection.
Ho YC; Sun HY; Chen MY; Hsieh SM; Sheng WH; Chang SC
J Microbiol Immunol Infect; 2008 Oct; 41(5):386-92. PubMed ID: 19122919
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
[TBL] [Abstract][Full Text] [Related]
8. HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV.
Guiguet M; Furco A; Tattevin P; Costagliola D; Molina JM;
HIV Med; 2007 Mar; 8(2):124-30. PubMed ID: 17352769
[TBL] [Abstract][Full Text] [Related]
9. Toxoplasmic encephalitis in acquired immunodeficiency syndrome.
Chaddha DS; Kalra SP; Singh AP; Gupta RM; Sanchetee PC
J Assoc Physicians India; 1999 Jul; 47(7):680-4. PubMed ID: 10778586
[TBL] [Abstract][Full Text] [Related]
10. A preliminary study of the frequency of focal neurological deficits in HIV/AIDS patients seropositive for Toxoplasma gondii IgG in Lagos, Nigeria.
Oshinaike OO; Okubadejo NU; Ojini FI; Danesi MA
Nig Q J Hosp Med; 2010; 20(3):104-7. PubMed ID: 21033315
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial.
Miro JM; Lopez JC; Podzamczer D; Peña JM; Alberdi JC; Martínez E; Domingo P; Cosin J; Claramonte X; Arribas JR; Santín M; Ribera E;
Clin Infect Dis; 2006 Jul; 43(1):79-89. PubMed ID: 16758422
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988-1995. HEMOCO and SEROCO Study Groups.
Belanger F; Derouin F; Grangeot-Keros L; Meyer L
Clin Infect Dis; 1999 Mar; 28(3):575-81. PubMed ID: 10194081
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
[TBL] [Abstract][Full Text] [Related]
14. Toxoplasmosis in HIV/AIDS patients: a current situation.
Nissapatorn V; Lee C; Quek KF; Leong CL; Mahmud R; Abdullah KA
Jpn J Infect Dis; 2004 Aug; 57(4):160-5. PubMed ID: 15329448
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era.
Abgrall S; Rabaud C; Costagliola D;
Clin Infect Dis; 2001 Nov; 33(10):1747-55. PubMed ID: 11595976
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
[TBL] [Abstract][Full Text] [Related]
17. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
[TBL] [Abstract][Full Text] [Related]
18. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994].
Bossi P; Caumes E; Astagneau P; Li TS; Paris L; Mengual X; Katlama C; Bricaire F
Rev Med Interne; 1998 May; 19(5):313-7. PubMed ID: 9775164
[TBL] [Abstract][Full Text] [Related]
20. Risk of toxoplasmic encephalitis in AIDS patients: indications for prophylaxis.
Dunlop O; Rootwelt V; Sannes M; Goplen AK; Abdelnoor M; Skaug K; Baklien K; Skar A; Melby K; Myrvang B; Bruun JN
Scand J Infect Dis; 1996; 28(1):71-3. PubMed ID: 9122637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
